| Vol. 13.10 – 14 March, 2024 |
| |
|
|
| Investigators demonstrated that the serum level of malondialdehyde, an index of lipid peroxidation, positively correlated with IL-13 level and negatively correlated with the predicted forced expiratory volume in one second in asthmatics. [Redox Biology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers determined if endoplasmic reticulum stress and the unfolded protein response signaling were involved in thymic stromal lymphopoietin induction in the airway epithelium. [American Journal Of Physiology-Lung Cellular And Molecular Physiology] |
|
|
|
| Investigators characterized the functional role of CD26/Dipeptidyl peptidase-4 (DPP4) expression in lipopolysaccharide-induced lung injury in mice, isolated alveolar macrophages, and cultured lung endothelial cells. [American Journal Of Physiology-Lung Cellular And Molecular Physiology] |
|
|
|
| Scientists investigated the regulatory mechanism of Tempol in the treatment of acute lung injury (ALI). A mouse model of ALI was established, and HE staining was used to examine histomorphology. [Journal of Biochemical and Molecular Toxicology] |
| |
|
|
| The authors clarified that mitogen-activated protein kinase 1-mediated phosphorylation at Ser90 was the key mechanism underlying serine hydroxymethyltransferase 2 (SHMT2) upregulation in lung adenocarcinoma. [Advanced Biology] |
|
|
|
| Quantitative real-time PCR and western blot were employed to detect the mRNA and protein levels of SF3B4, Sm-like protein 4 (LSM4), and methyltransferase-like 3 (METTL3). [Thoracic Cancer] |
|
|
|
|
| The authors explore some of the recent advances in this field and the evolving knowledge of the role of extracellular vesicles in bronchopulmonary dysplasia. [American Journal Of Physiology-Lung Cellular And Molecular Physiology] |
|
|
|
|
| The Lung Cancer Research Foundation (LCRF) announced three research grant awards focused on further understanding of the mechanism of action of antibody drug conjugates (ADCs) and exploring the use of ADCs in lung cancer types beyond NSCLC. [Lung Cancer Research Foundation] |
|
|
|
|
| April 7 – 10, 2024 San Diego, California, United States |
|
|
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| University of Denmark – Lyngby, Denmark |
|
|
|
| University of Texas Health Science Center – Houston, Texas, United States |
|
|
|
| University of Wisconsin – Madison, Wisconsin, United States |
|
|
|
| Augusta University – Augusta, Georgia, United States |
|
|
|
|